Catalyst Wire Dossier Catalyst Wire Dossier

DA-EPOCH-R Rituximab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DA-EPOCH-R Rituximab, covering 2017-11-17 to 2017-11-17. Get the full timeline:

Most recent: Clinical Trial Update: DA-EPOCH-Rituximab/Metformin (RM) for Double Hit Lymphoma [Phase 2]

See pricing